Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Toreforant

Next Previous
X
Search
Drug Profile

Toreforant

Alternative Names: H4R antagonist; Histamine 4 Receptor antagonist; JNJ-168; JNJ-38518168; JNJ-38518168-ZBQ

Latest Information Update: 05 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development
  • Developer Janssen Research & Development
  • Class Antiasthmatics; Antihistamines; Antipruritics; Antipsoriatics; Antirheumatics; Benzimidazoles; Diaminopyrimidines; Piperidines; Small molecules
  • Mechanism of Action Histamine H4 receptor antagonists; Th1 cell modulators; Th17 cell modulators; Th2 cell modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Asthma; Rheumatoid arthritis
  • No development reported Plaque psoriasis; Pruritus

Most Recent Events

  • 08 Sep 2021 No development reported - Phase-II for Plaque psoriasis in Poland, USA (PO) (Janssen Research & Development pipeline, September 2021)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Rheumatoid-arthritis(In volunteers) in Belgium (PO, Liquid)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Pruritus in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top